In clinical trials
Immune & defense
Aviptadil
Evidence
Clinical trials
Class
Synthetic vasoactive intestinal peptide (VIP)
KEY TAKEAWAY
Aviptadil is a synthetic form of vasoactive intestinal peptide, a 28-amino-acid hormone found in the lungs and gut. Aviptadil is not FDA-approved in the United States. It has been used in some countries for erectile dysfunction, and trials in lung conditions have not led to approval.
Written by the Veylo editorial team · Updated
November 2026
What it is
Synthetic vasoactive intestinal peptide (VIP)
Being studied for
Studied in lung disease, severe COVID-19 respiratory failure and erectile dysfunction
Key fact
Aviptadil is not FDA-approved in the United States. It has been used in some countries for erectile dysfunction, and trials in lung conditions have not led to approval.
Route
Injection or inhaled form in studies
Evidence strength
Clinical trials
Aviptadil is a synthetic form of vasoactive intestinal peptide, a 28-amino-acid hormone found in the lungs and gut.
It relaxes blood vessels and airways and has anti-inflammatory effects in the lung.
Aviptadil is not FDA-approved in the United States. It has been used in some countries for erectile dysfunction, and trials in lung conditions have not led to approval.
Studied in lung disease, severe COVID-19 respiratory failure and erectile dysfunction.
Flushing, headache and low blood pressure can occur.
Aviptadil: see PubMed and ClinicalTrials.gov for published studies and registered trials. No FDA drug label exists for the uses described.
Veylo content is educational and not medical advice. Peptides that are not FDA-approved are not approved for the uses described.